Tiffany Juarez
Protocol Development Manager
Institution:
Kesari Lab
La Jolla, CA, United States
https://www.mysciencework.com/profile/tiffany.juarez
Summary
Published articles Show More
Retrospective analysis of safety and feasibility of a 3 days on/11 days off temozolomide dosing regimen in recurrent adu...
Published in CNS Oncology
Hyaluronan expression in primary and secondary brain tumors.
Published in Annals of Translational Medicine
Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases.
...
Published in Cancer Cell International